PTPN22 inhibitors

Overview

Inhibitors of PTPN22 for cancer immunotherapy.


Status


Purdue Faculty

Dr. Zhong-Yin Zhang


Research Articles

Systemic inhibition of PTPN22 augments anticancer immunity

Structure-Activity Relationship Studies and Design of an PTPN22 Inhibitor with Enhanced Isozyme Selectivity and Cellular Efficacy

A Potent and Selective Quinolone-Based PTPN22 Inhibitor with Improved Immunotherapeutic Activity